MedPath

Dexamethasone

Dexamethasone Tablets USP

Approved
Approval ID

2ceb3a01-f5bb-4538-b5c1-cea400901d02

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 3, 2023

Manufacturers
FDA

PD-Rx Pharmaceuticals, Inc.

DUNS: 156893695

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dexamethasone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43063-266
Application NumberANDA087916
Product Classification
M
Marketing Category
C73584
G
Generic Name
Dexamethasone
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 3, 2023
FDA Product Classification

INGREDIENTS (5)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT
DEXAMETHASONEActive
Quantity: 2 mg in 1 1
Code: 7S5I7G3JQL
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Dexamethasone - FDA Drug Approval Details